Nantahala Capital Management, LLC Neuroone Medical Technologies Corp Transaction History

Nantahala Capital Management, LLC

  • $2.29 Billion
  • Q2 2025

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.66 - $1.07 $100,452 - $162,854
-152,200 Reduced 16.0%
798,762 $790,000
Q2 2024

Aug 14, 2024
SELL
$0.68 - $1.27 $168,606 - $314,896
-247,950 Reduced 20.68%
950,962 $760,000
Q1 2024

May 15, 2024
SELL
$1.03 - $1.62 $15,637 - $24,594
-15,182 Reduced 1.25%
1,198,912 $1.44 Million
Q4 2023

Feb 14, 2024
SELL
$0.86 - $1.92 $30,879 - $68,939
-35,906 Reduced 2.87%
1,214,094 $1.92 Million
Q3 2023

Nov 14, 2023
BUY
$0.85 - $1.99 $1.06 Million - $2.49 Million
1,250,000 New
1,250,000 $1.11 Million

Others Institutions Holding NMTC

# of Institutions
33
Shares Held
13.5M
Call Options Held
125K
Put Options Held
0
View Full List

About NEUROONE MEDICAL TECHNOLOGIES Corp

NMTC Quotes by TradingView
  • Ticker NMTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,209,200
  • Market Cap $13.3M
  • Description
  • NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...
More about NMTC
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email